Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation
Authors: Hicks, C.; Wong, R.; Manoharan, A.; Kwan, Y.
Source: Annals of Hematology, Volume 86, Number 8, August 2007 , pp. 591-598(8)
Publisher: Springer
Abstract:
Both CD34 (cluster of differentiation 34) and the more recently described CD133 are markers of primitive stem cells with haematopoietic repopulating ability. Most transplanting centres use a minimum number of CD34+ cells as the requirement for a transplant and consider this a predictor of haematopoietic engraftment. However, transplanted CD34+ cell dose does not always give a close correlation with time to engraftment nor explain delayed engraftment in some patients. We have retrospectively evaluated the potential of measuring viable CD133+ cell numbers in the autograft as an alternative predictor of haematological engraftment after autologous stem-cell transplantation in a cohort of patients with multiple myeloma (MM). We found an average 32% loss of viability of CD34+ cells in the post-thaw sample compared with the fresh sample. Of the original estimated CD34+ cell numbers transplanted per kg, 43% of the thawed samples were double positive for CD34+/CD133+. In this patient group, the CD34+/CD133+ subset gave the closest statistical correlation with time to neutrophil engraftment (p < 0.05), particularly for patients given above median (1.8 × 106/kg) dose of the double-positive cells. The CD34+/CD133+ population was the only parameter to give a significant correlation with white cell engraftment in this patient cohort (p < 0.05). There was no significant correlation between CD34+, viable CD34+ or viable CD34+/CD133+ cells/kilogram with platelet engraftment. Determination of viable CD34+/CD133+ progenitor cell dose in the autograft may be a useful tool to predict neutrophil recovery after autologous transplantation than conventional assessment of CD34+ numbers. These results warrant further investigation of the role of CD133 in haematopoietic engraftment.Keywords: CD34; CD133; Stem cells; Haematopoiesis; Engraftment; Multiple myeloma
Document Type: Research article
DOI: http://dx.doi.org/10.1007/s00277-007-0297-3
Affiliations: 1: Email: christine.hicks@unsw.edu.au
Publication date: 2007-08-01
- In this: publication
- By this: publisher
- In this Subject: Medicine , Oncology , Public Health
- By this author: Hicks, C. ; Wong, R. ; Manoharan, A. ; Kwan, Y.

Shopping cart
Receive new issue alert